Literature DB >> 6159423

Mechanism of lymphocyte activation. II. Requirements for macromolecular synthesis in the production of lymphokines.

L Varesio, H T Holden, D Taramelli.   

Abstract

Reversible inhibitors of protein synthesis, cycloheximide and puromycin, and an irreversible inhibitor of RNA synthesis, actinomycin D, were employed to study the kinetics and types of macromolecular synthetic events required for the production of migration inhibitory factor (MIF) and macrophage activating factor (MAF) by Con A-stimulated lymphocytes. Reversible inhibition of protein synthesis during the first 2 hr of stimulation completely inhibited MIF and MAF production. The same treatment, performed 4 hr after the beginning of the stimulation, had no effect. When the inhibitors of protein synthesis were left in the cultures, a block of lymphokine production was observed when the drugs were added at 6 hr as well as at time 0. In contrast, irreversible inhibition of RNA synthesis at 6 hr was ineffective and only treatment at the beginning of culture blocked lymphokine production. These data suggest that a critical protein is synthesized during the first few hours of stimulation, which is required for subsequent production of lymphokines. After this special early requirement, however, continued protein synthesis is needed for lymphokine production. In contrast, the RNA required for MIF and MAF production seemed to be completely synthesized within 4 to 6 hr of stimulation. The possibility that suppressor macrophages inhibit lymphokine production via modulation of macromolecular synthesis is discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6159423

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  Detection of early gene expression changes during activation of human primary lymphocytes by in vitro synthesis of proteins from polysome-associated mRNAs.

Authors:  S Miyamoto; J Qin; B Safer
Journal:  Protein Sci       Date:  2001-02       Impact factor: 6.725

Review 2.  Immunotherapy of malignant gliomas using autologous and allogeneic tissue cells.

Authors:  F M Hofman; A Stathopoulos; C A Kruse; T C Chen; V E J C Schijns
Journal:  Anticancer Agents Med Chem       Date:  2010-07       Impact factor: 2.505

3.  Lack of a relationship between immune function and chemically induced hepatocarcinogenesis in B6C3F1 mice.

Authors:  D R Germolec; R R Maronpot; M F Ackermann; S J Vore; K Dittrich; G J Rosenthal; M I Luster
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

4.  Immune (gamma) interferon production by a murine T cell lymphoma: requirements for macromolecular synthesis and lack of relationship with cell cycle.

Authors:  M Sarzotti; S Landolfo; F Dianzani
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.